Center for Medical Genetics and Genomics, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China; The Guangxi Health Commission Key Laboratory of Medical Genetics and Genomics, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
The Second School of Medicine, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
J Thromb Haemost. 2024 Dec;22(12):3431-3447. doi: 10.1016/j.jtha.2024.08.013. Epub 2024 Sep 12.
Targeted long-read sequencing (LRS) is expected to comprehensively analyze diverse complex variants in hemophilia A (HA) and hemophilia B (HB) caused by the F8 and F9 genes, respectively. However, its clinical applicability still requires extensive validation.
To evaluate the clinical applicability of targeted LRS-based analysis compared with routine polymerase chain reaction (PCR)-based methods.
Gene variants of retrieved subjects were retrospectively and prospectively analyzed. Whole-genome sequencing was performed to further analyze undiagnosed cases. Breakpoints of novel genomic rearrangements were mapped and validated using long-distance PCR and long-range PCR combined with sequencing.
In total, 122 subjects were retrieved. In retrospective analysis of the 90 HA cases, HA-LRS assay showed consistent results in 84 cases compared with routine methods and characterized 6 large deletions with their exact breakpoints confirmed by further validation in 6 cases (routine methods only presented failure in amplifying the involved exons). In prospective analysis of the 21 HA subjects, 20 variants of F8 were identified in 20 cases. For the remaining HA patient, no duplication/deletion or single-nucleotide variant (SNV)/insertion and deletion (InDel) was found, but a potential recombination involving exons 14 and 21 of F8 was observed by LRS. Whole-genome sequencing analysis and further verification defined a 30 478 base pairs (bp) tandem repeat involving exons 14 to 21 of F8. Among the 11 HB patients, HB-LRS analysis detected 11 SNVs/InDels in F9, consistent with routine methods.
Targeted LRS-based analysis was efficient and comprehensive in identifying SNVs/InDels and genomic rearrangements of hemophilia genes, especially when we first expanded the panel to include F9. However, further investigation for complex gross rearrangement is still essential.
靶向长读测序(LRS)有望全面分析分别由 F8 和 F9 基因引起的血友病 A(HA)和血友病 B(HB)的多种复杂变异。然而,其临床适用性仍需要广泛验证。
评估基于靶向 LRS 的分析与常规聚合酶链反应(PCR)方法相比的临床适用性。
对检索到的受试者的基因变异进行回顾性和前瞻性分析。对未确诊的病例进行全基因组测序分析。使用长距离 PCR 和长距离 PCR 结合测序,对新型基因组重排的断点进行映射和验证。
共检索到 122 例受试者。在 90 例 HA 病例的回顾性分析中,HA-LRS 检测与常规方法相比在 84 例中结果一致,并在 6 例中精确地确定了 6 个大片段缺失的断点,进一步验证(常规方法仅在扩增涉及的外显子时失败)。在 21 例 HA 患者的前瞻性分析中,20 例 F8 变异在 20 例中得到鉴定。对于其余的 HA 患者,未发现缺失/重复或单核苷酸变异(SNV)/插入和缺失(InDel),但通过 LRS 观察到涉及 F8 外显子 14 和 21 的潜在重组。全基因组测序分析和进一步验证定义了一个 30478 个碱基对(bp)串联重复,涉及 F8 的外显子 14 至 21。在 11 例 HB 患者中,HB-LRS 分析检测到 F9 中的 11 个 SNV/InDel,与常规方法一致。
基于靶向 LRS 的分析在识别血友病基因的 SNV/InDel 和基因组重排方面高效且全面,尤其是当我们首次扩展面板以包含 F9 时。然而,对于复杂的大体重排仍需要进一步研究。